Mathias Niedhammer

The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy—an open-label, prospective, randomised controlled multicenter study

C. Schade-Brittinger, W. Oertel, H. Lerche, 2012, Journal of Neurology, Neurosurgery & Psychiatry.